chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash is noticeably better /  skin color has lightened  / blood pressure seems lower; This case was reported by a consumer via call center representative and described the occurrence of unexpected therapeutic effect in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for an unknown indication.   The patient's past medical history included neck pain and shoulder pain. Concurrent medical conditions included rash, blood pressure and spinal cord injury (right side of his spinal cord over the years).   On 29th November 2020, the patient received the 1st dose of Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. On 29th November 2020, less than a day after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced unexpected therapeutic effect. On an unknown date, the outcome of the unexpected therapeutic effect was unknown.   It was unknown if the reporter considered the unexpected therapeutic effect to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows: The patient had high blood pressure and a rash on his right arm and right side of his face for 8 to 9 years. The patient had experienced pain on the right side of neck and right shoulder blade and right side of his spinal cord over the years. The rash on the right side of his face was described as presenting on the jaw looks like a vine.  The patient received Shingrix on the right arm and Flu vaccine on the left arm. The patient reported that the rash was noticeably better.  The skin color where the rash was dark and it had lightened since yesterday. He also said his blood pressure seems lower since getting the vaccine yesterday.
Headache, nausea, and arm pain on 3/8/22. Headache, nausea, arm pain, and severe chills on 3/9/22.
This spontaneous report as received from a pharmacist refers to 65 years old patient of unknown gender. On 28-OCT-2013, the patient was vaccinated with a pediatric dose of VAQTA (Lot number, expiry date and route were not reported) 0.5 milliliter (ml), instead of an adult dose of RECOMBIVAX HB. The patient was also previously vaccinated with 2 pediatric doses of VAQTA to equal one adult dose. No adverse effects reported. This is one of the two reports received from the same reporter link(MARRS# 1311USA000127). Additional information is not expected.
Chest pain, pericarditis, prolonged QT cycles heart. Constant chest pain containing through December 2021
tested positive for COVID-19/all the COVID-19 symptoms icky, fever, sore throat, snotty nose, chest congestion and cough; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID.  A 72-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 08Nov2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious) with onset 09Nov2023, outcome "unknown", described as "tested positive for COVID-19/all the COVID-19 symptoms icky, fever, sore throat, snotty nose, chest congestion and cough". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Reporter and patient took the vaccine, and they were having symptoms. They were both testing positive. The reporter would like to know if that was because of the vaccine. The reporter mentioned she and patient (her husband) travelled during the weekend and got the Pfizer COVID-19 vaccine last evening (08Nov2023). Today (09Nov2023), they both tested positive for COVID-19. Patient "was miserable". He was experiencing all the COVID-19 symptoms icky, fever, sore throat, snotty nose, chest congestion and cough.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Covid Vaccine Dose 1- 2/3/2021- Moderna Lot #042L20A. Covid Vaccine Dose 2- 2/24/ 2921- Pfizer Lot # EM9809. Covid Vaccine  Dose 3- 05/10/2021- Janssen Lot # 203A21A. Covid Vaccine Dose 4- 10/08/2021- Pfizer Lot # FF2590 local Pharmacy.
I was slightly dizzy after injection but nothing serious. That dizziness has continued through today, which is 72 hours later. Also, the dizziness is more pronounced.  In addition, I have experienced nasal congestion and facial swelling. These symptoms seem to be abating.
This spontaneous report was received from a registered nurse via a company representative and refers to a 19 year old male patient. The patient did not have any concomitant medications, concurrent conditions, medical history and drug reaction or allergies. On 14-SEP-2018, the patient was vaccinated with an expired dose of VAQTA lot # N020503, expiration date 04-SEP-2018, intramuscularly, (dose was not reported) for prevention of Hepatitis A. No adverse events were reported. It was also mentioned that no treatment or laboratory tests were performed. Also, no product quality complaint (PQC) was involved.
2 days after Zostavax, patient developed welt-like rash, mostly on arms after exercise. Subsided after couple of hours, then occurred similarly the next day after exercising. Has now resolved.
CHILLS; SORE ARM; PINGS OF A HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced chills, sore arm, and pings of a headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pings of a headache, chills and sore arm was not reported. This report was non-serious.
pt recv vax 9DEC97 & w/in 15 days of vax pt devel a cardiomyopathy;pt was hosp on 24DEC97 & event was considered life threatening;
Patient admitted to hospital 11/7/04 with right facial droop. Had received Pneumovax 23 on 10/07/04. Stated that 2-3 hours after vaccination, had significant arm swelling to right upper arm. Did not seek medical attention until co-worker noted right facial droop. Discharge Summary received on 1/06/2005 states Bell's Palsy, Anisocoria, elevated BP and endometrial cyst .
skin inflammation; redness when exposed to direct or indirect sunlight even with spf 85; Skin burns; itches on face and neck; This is a spontaneous report from a contactable consumer (patient).  A 64-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8733) via an unspecified route of administration in Arm Left on 28Mar2021 at 14:45 (at 64 years) as single dose for covid-19 immunisation. Medical history included hypothyroid. No known allergies. Covid prior vaccination and no covid tested post vaccination. Concomitant medications included clopidogrel bisulfate (PLAVIX) and bupropion hydrochloride (WELLBUTRIN) both taken for an unspecified indication and hypothyroid medications (unspecified).  Previously on 07Mar2021 at 15:30 (at 64 years) the patient took the first dose of the vaccine (lot EN6206) in Left arm for covid-19 immunisation. On 22May2021 patient experienced skin inflammation, redness, skin burns and itches on face and neck. Clinical course was reported as follows: on 22May2021 extreme reaction to mosquito bites, skin inflammation and redness when exposed to direct or indirect sunlight even with spf 85. Looked like 2nd degree burns. Skin burns and itches on face and neck whenever outside. Events resulted in doctor or other healthcare professional office/clinic visit and were serious due to disability or permanent damage.Steroid cream was given as treatment. The final outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected
Nausea and dizziness approximately 10-min after receiving injection lasting 4 days Fatigue later in the day lasting 4 days Painful arm around injection site lasting 3 days Painful skin on torso (feeling like being bruised) beginning on day after injection lasting 3 days Chills beginning on day after injection lasting 3 days
4 months since the first dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (4 months since the first dose) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, CETIRIZINE HYDROCHLORIDE (CETRIZINE), DOCUSATE SODIUM (COLACE), MORNIFLUMATE (FLOMAX [MORNIFLUMATE]), FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), MACROGOL 3350 (MIRALAX), MELATONIN, NITROGLYCERIN, OMEPRAZOLE, TRAMADOL, TRAZODONE and RIVAROXABAN (XARELTO) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (4 months since the first dose). On 24-May-2021, PRODUCT DOSE OMISSION ISSUE (4 months since the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication use was not provided by the reporter.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose02/04/21 2nd dose03/06/21 Diagnosed covid positive:08/25/21 Symptom onset:08/21/21 Exposure: Symptoms:fatigue ,nasal congestion, light headedeness,,
Within 72 hours I began to exhibit signs of blood clotting in the big toe on my left side (same side of my body where I was injected).  Over one third of the nail discolored a dark purple, as if I had dropped a weight on it, or stubbed it.  Likewise, I also had similar clotting and discoloration on my middle toenail on the left foot.  To date, the clotting on the middle toe has mostly gone away.  However, the clotting on the left nail is still present, still very dark purple, and has only begun to diminish slightly around the edges.  Additionally, within 2-3 weeks I began to experience head and neck pain, as if I had encephalitis, with the feeling of swelling/internal pressure in the back of my head and upper neck, and severe stiffness and pain in my lower neck.  I also began to experience SIRVA-like symptoms in my left shoulder, rotator cuff, and front part of the collar bone.  These pains, and those of the neck, were only alleviated by an anti-inflammatory medication (aspirin, Aleve, etc).  I also experienced "brain fog" where I had difficulty concentrating and focusing on tasks, and I also experienced unexplained pains in my left arm that would throb in synchronization with my pulse.  I would feel these pains in my upper and lower arms, and they would sometimes be acute for a few minutes and then disappear completely.  They were identical in sensation to when I had a real bloodclot, in my right arm, from a minor injury.  I had none of these symptoms prior to taking the vaccine.  Over time, they have faded, and I now feel almost completely normal.  But, for the 8-10 weeks following my second Moderna vaccine dose, I was plagued with numerous unexplained pains, aches, bloodclotting under the toenails, etc, that I can only attribute to the vaccine.  I have been subjected to numerous shots and vaccines over the course of my life and I have never had a reaction like this.
Patient received the COVID-19 vaccine at 5:17 pm. At 5:22 pm she said she was feeling dizzy, nauseated, fainting feeling. She couldn't stand up. Her BP was 70/41 with pulse 70 at 5:26 pm, then 87/58 with pulse 77 at 05:33 pm. EMT arrived at 05:35 and her vials improved to 110/80 with pulse 78. She recovered and didn't need assistance from EMT.
This spontaneous report as received from a healthcare worker regarding a patient of an unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 11-MAY-2015, the patient was vaccinated with VARIVAX (Merck) (lot # K011082, expiry date 08-AUG-2016) which was exposed to temperature excursion of 25F for 41hours. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Right arm sore. About 10pm, right shoulder and neck ache.  Chills and headache about 3am. Total body aches 5am
Started with headache and soreness at injection site on day of injection.  Next morning aching goes down back, up neck and into shoulders.  Right upper arm slightly swollen, and warm to touch under right arm and deltoid to elbow. Fever this am 99.1
Starting 7-10 days after vaccination, severe gas, cramping, and change to stools. Continued until PCP visit a month after. Started on Fiverr (Metamucil) but symptoms persisted..  About 60 days later, spoke with Gastroenterology which started probiotics. Symptoms improving, butt not back to normal.  Appt scheduled in May with Gastroenterology  N.B.  Influenza vaccine received five days AFTER COVID vaccine, so it doesn't show up on next page
At 1428 in post vaccination observation area, patient reports that directly after she was vaccintated, she began to feel hot and like her heart was racing. 1433 Reports feeling better now that there is a breeze.  At 1437 Patient reports, "I think I'm just feeling anxious." Continues to explain that she had been thinking about getting vaccinated  and how the thought of it was making her nervous.  Reports feeling at baseline and is ready to be released.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 05-OCT-2012 the patient was vaccinated with PNEUMOVAX 23 (lot # H013847, expiration date unknown) dose and route not reported. No concomitant medications were reported. The physician reported that the patient experienced adverse effects of malaise, fatigue, swelling, fever and under-arm pain. The date of birth was not available for this patient nor was the specific information about the patient. The patient did not recover from the reported events at the time of this report. Treatment was not given for the events. The patient sought medical attention by notifying the physician. The physician was enquiring if there had been an increase in reports of adverse effects from this lot of PNEUMOVAX 23 and was it possible that this lot of PNEUMOVAX 23 was contaminated. This is one of the several reports from the same reporter. Additional information has been requested.
Initial vaccination in right arm was extremely painful, like no other vaccine ever received. By same evening, right arm hurt badly as if I was punched in the arm badly. Sore upper arm lasted for the next week. Later same evening began to feel achy and a little feverish. By following morning, could not go to work because I had chills, fever, aches, and developed what appeared to be a hive on my left 5th finger. The hive lasted at least a week before reducing but it now comes and goes. Other than the hive, I mostly recovered by day 2 and was OK to go back to normal activities by 3rd day.
she had this shot and did have pneumonia years after receiving it; she had this shot and did have pneumonia years after receiving it; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient stated that this shot could help you from having pneumonia. She stated that she had this shot and did have pneumonia years after receiving it and the doctor advised her it could have been much worse if she had received this shot (as reported). Outcome of the event was unknown.   Information on the batch number has been requested.
Pt. was given varivax on 3/5/09. Within 10-15 mins. of receiving vaccine pt. complains of flushed face, stinging at injection site and redness at site. Pt. was placed back in exam room and given Benadryl 12.5mg po, pulse oximetry obtained a 100%. MD examined pt. ,lungs were clear on exam. Cool compress applied to injection site.Pt. returned to our clinic on 3/23/09 where mom states pt "had varivax on 3/5/09 and had an allergic reaction" symptoms on 3/23 visit were'sore throat and being tired'
After receiving the dose I had a hard red lump in my arm - which I expected, however almost a week after the lump is ~5cm in diameter and extremely itchy and red. Rash looks like a ton of goosebumps piled on top of each other. Three of my coworkers have also experienced this.
Patient reported she woke up the next day with a fever, chills, and swelling redness at the injection site. Fever reached 103 F and lasted 3 days. Patient also reported that she was incontinent of stools and was very weak. She presented to an emergency department which did not admit her but instructed her to rest and stay hydrated during illness. Patient recovered with 4 days.
Pt in clinic today for a different vaccine and reported this reaction:  angry red, tender, painful, warm left arm, had chills.  Photo on patient phone shows an irregularly shaped bright red area about 6 inches x 4 inches.  Spouse stated they postponed todays Hep B because he wanted this to be relieved.  Did not say when it was cleared up.  Left upper arm clear, free of erythema today, pt denies any s/s reported to be evident today.  There is nothing in patien'ts chart to indicate that our clinic was contacted about this reaction.
improperly stored dose of VAQTA administered; No adverse ffect; This spontaneous report was received from a registered nurse referred to a patient of unknown age and gender. The patient's historical conditions, past drugs, concomitant medications and concurrent conditions was not reported. On an unknown date the patient was vaccinated with hepatitis a vaccine, inactivated(VAQTA) (lot # S002460, expiry date 15-MAY-2020) (strength, dose and frequency not reported) intramuscularly for prophylaxis. On 24-JUN-2019, the patient administered improperly stored doses of with hepatitis a vaccine, inactivated(VAQTA) which was stored at a temperature of above 47 degree F (Fahrenheit) for 2 hours. There was no previous temperature excursion reported. The digital data logger was involved. No adverse effect reported. Product quality complaint was not involved.  This is one of several reports received from the same reporter.
The patient was seen in clinic yesterday where she received her flu shot, pneumococcal vaccine and tetanus shot. She received two injections in her right arm. Before bed the patient began to notice swelling in her right upper arm. The patient awoke around 4 am and reports that her right arm was numb and she experienced severe pain only slightly relieved with lortab. Today she notes that the pain and swelling are somewhat improved. Her sensation is intact today, however, she required assistance with dressing this am 2/2 pain when lifting her arm.
Pt w/ prolapsed ileostomy. Went to OR and noted to have intussusscepted 18cm small bowel. 36cm had to be resected, ileostomy was revised.
At 10;30 pm starting running a temp of 99.9, started shivering uncontrollably. Took 2 advil 200mg. ea. woke again at 1:00 am with a temp of 101.6. My heart was beating fast so I took my blood pressure and it was 164/85, my heart rate/pulse was at 125 per min.. Took 2 more advil. kept checking my rates. at 2;30 am. it was  136/73  with a heart rate/pulse of 117. Temp 100.9. stayed awake till 4;30 am. thinking about going to hospital.  When i woke at 7:00 am my  BP had gone to 121/77 with heart rate of and temp of 99.9. I took more advil and slept most of the day. Was very fatigued. this lasted until that evening of the 8th.  On the whole, it was a 24hr reaction period. From 10:30 pm. on the dosage day to 10:30 pm on the day after.
Eleven days after receiving the vaccine,12mar2021rash on both sides of her body; rash would start out as a red and itchy and then fade to a slight pinkish color; rash would start out as a red and itchy and then fade to a slight pinkish color and would go away; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Eleven days after receiving the vaccine,12mar2021rash on both sides of her body), RASH ERYTHEMATOUS (rash would start out as a red and itchy and then fade to a slight pinkish color) and RASH PRURITIC (rash would start out as a red and itchy and then fade to a slight pinkish color and would go away) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced RASH (Eleven days after receiving the vaccine,12mar2021rash on both sides of her body), RASH ERYTHEMATOUS (rash would start out as a red and itchy and then fade to a slight pinkish color) and RASH PRURITIC (rash would start out as a red and itchy and then fade to a slight pinkish color and would go away). On 25-Mar-2021, RASH (Eleven days after receiving the vaccine,12mar2021rash on both sides of her body), RASH ERYTHEMATOUS (rash would start out as a red and itchy and then fade to a slight pinkish color) and RASH PRURITIC (rash would start out as a red and itchy and then fade to a slight pinkish color and would go away) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products reported  No treatment products reported
tested positive for Covid 19 on 6/13/2022; also please note i had my shingles vaccines around this same time (one a month prior to my 4th covid booster and the second about a month before i got covid)
PER SPOUSE, HE HAD A CUT ON HIS LEG THAT DID NOT STOP BLEEDING.  THEY WENT TO CLINIC TO GET IT CAUTERIZED.  DAY LATER HIS BODY HAD MULTIPLE BRUISES, THEN HE WAS EVEN BLEEDING FROM HIS PENIS.  AT HOSPITAL THEY TOLD HIM HE HAD LOW PLATELETS AND WAS BLEEDING OUT.    HE WENT INTO HOSPICE AND PASSED AWAY ON 5/8/2021
Pain & soreness at injection sight extending from neck/shoulder to elbow, full body muscle aches, headache, nausea & vomiting, fever of 101.9- fever and nausea  subsided by next morning (within 12 hours).
pt had vax in 3/96 & in 8/98 pt exp small, red papules on torso, arms, neck & chest, scattered rash w/between 50-100 bumps. pt was febrile on days 2&3
Initial report received from a physician on 23 August 2007. A 22-year-old male patient was given Daptacel (lot number not reported) in August 2007 and developed mild nonspecific pain and achiness within the first 48 hours after the vaccination. These symptoms resolved but he developed muscle aches and joint pains on day 7. These symptoms resolved within 24 hours of their onset. It turns out that on day 7, he was working outdoors in >100 degree weather and he experienced dehydration. Once he was rehydrated and rested, he felt fine. The physician is no longer concerned that the symptoms are due to Daptacel. Follow-up information received on 15 October 2007 from a health care professional. The patient's date of birth was provided making the patient 22-years-old at the time of the event. Daptacel, lot number C2605AA, was administered in the left deltoid. Illness at the time of vaccination included viral symptoms. Past medical history was none.